67 related articles for article (PubMed ID: 24054064)
1. Expression and significance of leptin receptor, p-STAT3 and p-AKT in diffuse large B-cell lymphoma.
Lin S; YuJun L; XiaoMing X; WenWen R
Acta Histochem; 2014 Jan; 116(1):126-30. PubMed ID: 24054064
[TBL] [Abstract][Full Text] [Related]
2. Activation of the PI3K/AKT/mTOR pathway in diffuse large B cell lymphoma: clinical significance and inhibitory effect of rituximab.
Xu ZZ; Xia ZG; Wang AH; Wang WF; Liu ZY; Chen LY; Li JM
Ann Hematol; 2013 Oct; 92(10):1351-8. PubMed ID: 23636313
[TBL] [Abstract][Full Text] [Related]
3. Leptin receptor expression and its association with PI3K/AKT signaling pathway in diffuse large B-cell lymphoma.
Uddin S; Bu R; Ahmed M; Hussain AR; Ajarim D; Al-Dayel F; Bavi P; Al-kuraya KS
Leuk Lymphoma; 2010 Jul; 51(7):1305-14. PubMed ID: 20443680
[TBL] [Abstract][Full Text] [Related]
4. Hyperactivated STAT3 in ALK-positive diffuse large B-cell lymphoma with clathrin-ALK fusion.
Momose S; Tamaru J; Kishi H; Mikata I; Mori M; Toyozumi Y; Itoyama S
Hum Pathol; 2009 Jan; 40(1):75-82. PubMed ID: 18755494
[TBL] [Abstract][Full Text] [Related]
5. [Activation and clinicopathologic significance of AKT/mTOR signaling pathway in diffuse large B-cell lymphoma].
Yu BH; Zhou XY; Xiao XY; Yan SY; Qin T; Shi DR
Zhonghua Bing Li Xue Za Zhi; 2009 Jan; 38(1):35-41. PubMed ID: 19489223
[TBL] [Abstract][Full Text] [Related]
6. The rGel/BLyS fusion toxin inhibits STAT3 signaling via down-regulation of interleukin-6 receptor in diffuse large B-cell lymphoma.
Lyu MA; Sung B; Cheung LH; Marks JW; Aggarwal BB; Aguiar RC; Rosenblum MG
Biochem Pharmacol; 2010 Nov; 80(9):1335-42. PubMed ID: 20654581
[TBL] [Abstract][Full Text] [Related]
7. [The effect of leptin and its mechanisms on the migration and invasion of human breast cancer MCF-7 cells].
Wang L; Cao H; Pang X; Li K; Dang W; Tang H; Chen T
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Dec; 29(12):1272-6. PubMed ID: 24321071
[TBL] [Abstract][Full Text] [Related]
8. High immunohistochemical expression of p-AKT predicts inferior survival in patients with diffuse large B-cell lymphoma treated with immunochemotherapy.
Hasselblom S; Hansson U; Olsson M; Torén L; Bergström A; Nilsson-Ehle H; Andersson PO
Br J Haematol; 2010 May; 149(4):560-8. PubMed ID: 20201946
[TBL] [Abstract][Full Text] [Related]
9. SPIB is a novel prognostic factor in diffuse large B-cell lymphoma that mediates apoptosis via the PI3K-AKT pathway.
Takagi Y; Shimada K; Shimada S; Sakamoto A; Naoe T; Nakamura S; Hayakawa F; Tomita A; Kiyoi H
Cancer Sci; 2016 Sep; 107(9):1270-80. PubMed ID: 27348272
[TBL] [Abstract][Full Text] [Related]
10. Concurrent inhibition of PI3-kinase and mTOR induces cell death in diffuse large B cell lymphomas, a mechanism involving down regulation of Mcl-1.
Zang C; Eucker J; Liu H; Müller A; Possinger K; Scholz CW
Cancer Lett; 2013 Oct; 339(2):288-97. PubMed ID: 23200668
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive immunohistochemical approach of AKT/mTOR pathway and p-STAT3 in mycosis fungoides.
Levidou G; Siakantaris M; Papadaki T; Papadavid E; Vassilakopoulos TP; Angelopoulou MK; Marinos L; Nikolaou V; Economidi A; Antoniou C; Patsouris E; Korkolopoulou P
J Am Acad Dermatol; 2013 Sep; 69(3):375-84. PubMed ID: 23685026
[TBL] [Abstract][Full Text] [Related]
12. Leptin induces IL-8 expression via leptin receptor, IRS-1, PI3K, Akt cascade and promotion of NF-kappaB/p300 binding in human synovial fibroblasts.
Tong KM; Shieh DC; Chen CP; Tzeng CY; Wang SP; Huang KC; Chiu YC; Fong YC; Tang CH
Cell Signal; 2008 Aug; 20(8):1478-88. PubMed ID: 18501560
[TBL] [Abstract][Full Text] [Related]
13. STAT3 Expression and Activity are Up-Regulated in Diffuse Large B Cell Lymphoma of Dogs.
Assumpção ALFV; Jark PC; Hong CC; Lu Z; Ruetten HM; Heaton CM; Pinkerton ME; Pan X
J Vet Intern Med; 2018 Jan; 32(1):361-369. PubMed ID: 29119628
[TBL] [Abstract][Full Text] [Related]
14. Role of the long form leptin receptor and of the STAT3 signaling pathway in colorectal cancer progression.
Uchiyama T; Takahashi H; Endo H; Sugiyama M; Sakai E; Hosono K; Nagashima Y; Inayama Y; Wada K; Hippo Y; Nakajima A
Int J Oncol; 2011 Oct; 39(4):935-40. PubMed ID: 21720710
[TBL] [Abstract][Full Text] [Related]
15. STAT3 activation is associated with cerebrospinal fluid interleukin-10 (IL-10) in primary central nervous system diffuse large B cell lymphoma.
Mizowaki T; Sasayama T; Tanaka K; Mizukawa K; Takata K; Nakamizo S; Tanaka H; Nagashima H; Nishihara M; Hirose T; Itoh T; Kohmura E
J Neurooncol; 2015 Sep; 124(2):165-74. PubMed ID: 26080800
[TBL] [Abstract][Full Text] [Related]
16. [Leptin play the key role in astroglial differentiation of mouse neural stem cells and regulated the STAT3 signaling through Jak-STAT3 pathway].
Wang YN; Yang M; Yu LH; Guo J; Chen N; He L
Sichuan Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 45(4):552-6, 562. PubMed ID: 25286674
[TBL] [Abstract][Full Text] [Related]
17. TCL1 as a hub protein associated with the PI3K/AKT signaling pathway in diffuse large B-cell lymphoma based on proteomics methods.
Gao HX; Li SJ; Niu J; Ma ZP; Nuerlan A; Xue J; Wang MB; Cui WL; Abulajiang G; Sang W; Zhang W; Li XX
Pathol Res Pract; 2020 Feb; 216(2):152799. PubMed ID: 31932115
[TBL] [Abstract][Full Text] [Related]
18. AKT Hyperactivation and the Potential of AKT-Targeted Therapy in Diffuse Large B-Cell Lymphoma.
Wang J; Xu-Monette ZY; Jabbar KJ; Shen Q; Manyam GC; Tzankov A; Visco C; Wang J; Montes-Moreno S; Dybkær K; Tam W; Bhagat G; Hsi ED; van Krieken JH; Ponzoni M; Ferreri AJM; Wang S; Møller MB; Piris MA; Medeiros LJ; Li Y; Pham LV; Young KH
Am J Pathol; 2017 Aug; 187(8):1700-1716. PubMed ID: 28627414
[TBL] [Abstract][Full Text] [Related]
19. Leptin induces functional activation of cyclooxygenase-2 through JAK2/STAT3, MAPK/ERK, and PI3K/AKT pathways in human endometrial cancer cells.
Gao J; Tian J; Lv Y; Shi F; Kong F; Shi H; Zhao L
Cancer Sci; 2009 Mar; 100(3):389-95. PubMed ID: 19154413
[TBL] [Abstract][Full Text] [Related]
20. Intracellular leptin signaling following effective weight loss.
Sahin-Efe A; Polyzos SA; Dincer F; Zaichenko L; McGovern R; Schneider B; Mantzoros CS
Metabolism; 2015 Aug; 64(8):888-95. PubMed ID: 25998856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
